SPOTLIGHT -
May 10th 2024
Respondents said they were concerned about their own mental health or the mental health of another person at higher rates since 2022.
May 8th 2024
The industry must find a way to balance consumer privacy and a return on investment in pharma marketing.
April 29th 2024
Blankenship, vice president of policy initiatives and advocacy at The Academy of Nutrition and Dietetics, discusses how AOMs can play a role in creating strategies to manage the obesity epidemic.
April 24th 2024
April 15th 2024
Greater Than One’s Chief Strategy Officer, Andrew Bast, shares his takeaways from 2024 Rare Disease Summit in Philadelphia, PA.
Rutgers University, CMIC CMO to Collaborate on Pharma Manufacturing Efforts
Parties will establish a Center of Excellence in CMIC’s NJ plant.
Triveni Bio Launches with $92M Series A Financing
Company aims to develop functional antibodies for the treatment of immunological & inflammatory disorders.
Chime Biologics, Hope Medicine Strike Manufacturing Deal
Agreement aims to speed up the launch of endometriosis and androgenic alopecia treatment.
Caris Life Sciences, Moderna Ink Strategic Partnership Agreement
Collaboration to focus on advancing mRNA-based oncology therapeutics.
OptimizeRx Finishes Medicx Acquisition
Company to discuss acquisition and expansion of executive leadership.
Samsung Biologics, Kurma Partners Strike Development and Manufacturing Deal
Collaboration to focus on biologics of Kurma’s portfolio companies.
FDA Grants Certa Therapeutics’ FT011 Orphan Drug Designation
Investigational therapy indicated for the treatment of systemic sclerosis.
Citius Pharmaceuticals Agrees to Merge Wholly Owned Subsidiary with TenX Keane Acquisition
New company to be publicly listed as Citius Oncology, Inc.
Roche Reaches Definitive Agreement to Acquire Telavant
Deal includes rights to novel antibody for the treatment of inflammatory bowel disease.
FDA Clears Pfizer’s Meningococcal Disease Treatment
Penbraya indicated as the first and only vaccine for the prevention of the five most common serogroups in adolescents.
Daiichi Sankyo, Merck Set to Collaborate on Three DXd Antibody-Drug Conjugates
Companies to jointly develop candidates with potential commercialization agreements included.
GE Healthcare, Novo Nordisk Partner to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity
Joint venture combines GE’s background in ultrasound technology with Novo Nordisk’s experience with metabolic diseases.
FDA Clears Investigational New Drug Application for Lipella’s Oral Lichen Planus Treatment
LP-310 designated as an oral formulation of company’s LP-10 asset.
Thermo Fisher Scientific Acquires Olink
Transaction valued at approximately $3.1 billion.
Royalty Pharma Agrees to Purchase $1.5B in Royalties of Roche’s Evrysdi
Agreement includes option for PTC Therapeutics to sell up to all its retained royalties.
Actym Therapeutics Extends Series A Financing with Additional $25.5M Closing
Extra capital brings overall funding to $59.5 million.
Seegene Introduces New Recyclable, Styrofoam-Free Shipping Boxes
Initiative started as a response to climate change, company says.
FDA Clears Orasis Pharmaceuticals’ Presbyopia Treatment
Qlosi indicated for adult patients.
Everest Medicines, Pfizer Receive FDA Clearance for Ulcerative Colitis Treatment
Etrasimod indicated for adult patients with moderate-to-severe diagnosis.
Rite Aid Files for Bankruptcy, Launches Restructuring Plan
Drug supplier receives $3.45 billion in commitment in new financing.
FDA Clears Pfizer’s Braftovi + Mektovi for Non-Small Cell Lung Cancer Treatment
Treatment indicated for patients with BRAF V600E-mutant metastatic form of disease.
Novavax COVID-19 Vaccine Now Available at Numerous US Pharmacies
Treatment previously received emergency use authorization by the FDA.
FDA Clears IND for Kyverna Therapeutics’ Scleroderma Treatment
KYV-101 designed as a CD19 CAR T-cell therapy.
Bayer Opens $250M Cell Therapy Manufacturing Facility
Site aims to advance regenerative medicines on a global scale.
FDA Approves Novartis’ New Rheumatic Disease Treatment
Cosentyx is the first intravenous formulation interleukin-17A antagonist to focus on disease.
FDA Clears Actemra Biosimilar Tofidence
Developed by Bio-Thera Solutions, treatment is indicated for patients with three different types of arthritis.
Amgen Completes Purchase of Horizon Therapeutics
Acquisition includes company’s inflammatory disease medicines.
AbbVie Completes Acquisition of Mitokinin
Addition strengthens neuroscience pipeline, company says.
Q&A With Daniel Lofaso, CEO of Digital Elevator
Lofaso discusses strategies that biotech companies can take once its time to make the big push.
Kyowa Kirin Purchases Orchard Therapeutics
Transaction made with intent to develop new drugs, company says.